Pricing Log in Create free account

MiNK Therapeutics, Inc. (INKT) vs Mereo BioPharma Group plc - Sponsored ADR (MREO)

MiNK Therapeutics, Inc. and Mereo BioPharma Group plc - Sponsored ADR are both Biotechnology companies. MiNK Therapeutics, Inc. and Mereo BioPharma Group plc - Sponsored ADR are of similar size ($50.7M and $49.3M). Across the 7 metrics below, Mereo BioPharma Group plc - Sponsored ADR leads on 4 and MiNK Therapeutics, Inc. on 3.

Valuation

Metric INKT MREO Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B n/m 1.68 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (25.50%) (58.20%) (33.15%)
Free cash flow yield (14.61%) (53.23%) (25.50%)

Profitability

Metric INKT MREO Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 57.94% (67.85%) (56.36%)
Return on assets (187.78%) (57.73%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric INKT MREO Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) (2.45%) 10.16% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric INKT MREO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.23 5.88 4.72
Net debt to EBITDA 1.07 1.04 0.96

Dividend

Metric INKT MREO Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric INKT MREO Biotechnology median
Market cap 50.73m 49.34m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack